A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
Year: 2021
Type: review
Abstract: Chronic kidney disease (CKD) is a complex disease which affects approximately 13% of the world's population. Over time, CKD can cause renal dysfunction and progression to end-stage kidney disease and cardiovascular disease. Complications associated with CKD may contribute to the acceleration of disease progression and the risk of cardiovascular-related morbidities. Early CKD is asymptomatic, and symptoms only present at later stages when complications of the disease arise, such as a decline in kidney function and the presence of other comorbidities associated with the disease. In advanced stages of the disease, when kidney function is significantly impaired, patients can only be treated with dialysis or a transplant. With limited treatment options available, an increasing prevalence of both the elderly population and comorbidities associated with the disease, the prevalence of CKD is set to rise. This review discusses the current challenges and the unmet patient need in CKD.
Source: Advances in Therapy
Institutions: University Hospital Llandough, Health Economics and Outcomes Research (United Kingdom), University of Surrey, University Hospitals Birmingham NHS Foundation Trust, Swansea University, East Sussex Healthcare NHS Trust, University Hospital of Wales, Cardiff University, The Royal Free Hospital, University College London, University of Exeter
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,860
Funder: AstraZeneca
OpenAlex ID: W3208523646
